2 Best Cannabis Stocks to Buy in July 2022
The cannabis market is currently hitting fresh lows in June due to huge decreases in cannabis stock prices but what are the 2 best cannabis stocks to buy in July 2022?
The US MSOs’ moderate revenue growth in the first quarter of 2022 did not translate into market gains. As a result, a lot of cannabis investors engage in short-term trading of US marijuana stocks. Some long-term cannabis investors opt to trade around their long-term core assets using short-term strategies.
This enables them to profit from the daily fluctuations in the stock price. Recently, MSOs in the US have done better than any other income generators worldwide. Since the epidemic, they have performed better than Canadian LPs. In light of the market’s new lows in June, let’s examine 2 of the top marijuana stocks now trading on the OTC Market.
2 Best US Marijuana Stocks To Watch in July 2022
- Verano Holdings Corp. (OTC: VRNOF)
- Cresco Labs Inc. (OTC: CRLBF)
Verano Holdings Corp.
Verano Holdings is a marijuana business that offers clients legal marijuana and conducts business in several states. The business sells premium cannabis products under a variety of brand names. Verano now has 12 manufacturing and processing facilities in 15 states, along with 100 dispensaries. The business maintains a large influence in Florida thanks to its 47 dispensaries there. Zen LeafTM and MUVTM, two of the company’s retail brands, operate dispensaries that serve both medicinal and adult-use customers. On Flamingo Road in Las Vegas, the company opened a drive-through dispensary. Zen Leaf Westover, the company’s second dispensary in the state and it’s 100th nationwide, opened on May 26, Verano stated.
Sales increased 67 percent to $202 million in the first quarter of 2022, the business stated in May, compared to the same period the previous year. Furthermore, compared to the first quarter of 2021, when the gross profit was $54 million, the first quarter of 2022 saw a gross profit of $100 million, or 49% of revenue. Verano reported a $7 million net loss for the first quarter of 2022 as opposed to a $2 million loss for the same period the previous year. Importantly, the business achieved $81 million in unadjusted EBITDA, or 40% of sales, and $81 million in adjusted EBITDA, or 40% of revenue, in the first quarter of 2022.
How is VRNOF Stock Performing?
VRNOF shares closed at $6.97 on June 24th down 2.25% in the past five trading days. Currently, the stock has a 52-week price range of $6.28-$18.78 and is down 44.83% year to date. According to analysts at Tip Ranks VRNOF stock has a 12-month average price target of $24.45 per share. This would represent an increase of 250.76% from its last trading price of $6.97.
Cresco Labs Inc.
Cresco Labs is a cannabis corporation with a vertically integrated corporate structure established in the United States. The business is currently the leading producer of branded cannabis products in the country. According to a BDSA survey, Cresco is the most liked marijuana brand in Illinois and Pennsylvania. With 50 retail locations, 20 manufacturing facilities, and 47 retail licenses, Cresco operates in 11 states. As part of its expansion strategy, Sunnyside has opened its fourth dispensary in Pennsylvania. According to the company, new consumables and vaping alternatives will be added to the Good News product range. The business will switch to owned brand distribution in California to increase profitability and do away with the third-party distribution.
Sales for the first quarter were up 20% year over year at $214 million for the company. Additionally, after excluding the fair value markup for acquired items, gross profit is $113 million, or 53% of revenue, increasing 29% year over year. Adjusted EBITDA increased by 45 percent year over year to $51 million in the first quarter or 24 percent of revenue. With same-store sales up 9%, retail revenue climbed by 44% year over year to $119 million, or $2.5 million per average store open during the quarter.
At the end of the quarter, Cresco had $179 million in cash on hand and had added four new retail locations, for a total of 50, with three in Florida and one in Pennsylvania. Additionally, the business introduced its branded product line, which consists of Sunnyside* Chews, High Supply(R), Good News(R), and RemediTM, in Florida during the first quarter. Cresco recently acquired Columbia Care Inc. (OTC: CCHWF), giving it a $2 billion valuation and making it the new leader in the cannabis industry.
How is CRLBF Stock Performing?
CRLBF shares finished on June 24th at $2.79, down 7.62% for the last five trading days. The stock is presently trading in a 52-week price range of $2.71-11.947, showing a 58.17 percent decline year to date. According to analysts at CNN Business CRLBF stock has a 12-month median price target of $11.71 per share. In this case, this represents an upside of 319.55% from its last trading price of $2.79.
2 Best Cannabis Stocks to Buy in July 2022
About Cannin: Your Cannabis Stocks Resource
78% of Cannin’s fundamentals prove true within 30 days or less on 100+ recommendations over the past 2 years.
Cannin is your #1 trusted resource for cannabis stocks. Our global team of experts evaluates all emerging cannabis stock investing opportunities. In fact, we aggregate hundreds of hours of financial research and provide tips on the best cannabis stocks for 2021.
Use Cannin as your resource for:
Market analysts expect the marijuana and hemp industry will have an annual value exceeding $75 Billion in the next decade. Is it too late to invest in marijuana stocks? No! This is the perfect time to invest.
Are you looking to buy stock in hemp companies or marijuana companies for 2021? If so, are you interested in new penny hemp stock companies? Or, looking for the best Canadian cannabis stocks to invest in? Maybe, you’re looking to leverage the power of algorithmic stock trading to beat the cannabis market? We can help.
Are you interested in cannabis stocks like Curaleaf, Trulieve, Aurora Cannabis, Charlotte’s Web, Canopy Growth, or Hemp Inc.?
Predict price movements of cannabis stocks several hours in advance with our proprietary algorithmic stock trading software.
- +34% Gains in 2022
- +56% Gains in 2021
- +30% Gains in 2020
- +49.8% Gains in 2019
- Backtested since 2012
In fact, we’re so confident you’ll love our algotrading cannabis stock signals, we’re willing to give you a one week risk-free trial to see it for yourself.
Profit from the best cannabis stocks – we’ll show you how at cannin.com.